期刊文献+

成簇的规律间隔短回文重复序列及其相关蛋白9基因编辑技术在抗乙型肝炎病毒感染治疗中的应用 被引量:1

Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBVinfection
原文传递
导出
摘要 缺乏有效根除乙型肝炎病毒(HBV)的药物及技术手段是限制HBV感染无法治愈的瓶颈。成簇的规律间隔短回文重复序列及其相关蛋白9系统是近年来新兴的对特定基因位点进行编辑的技术,可以特异性靶向HBV共价闭合环状DNA,有效抑制HBV DNA复制、调控HBV功能蛋白表达,有望成为彻底根除HBV的强有力基因治疗工具。如何利用成簇的规律间隔短回文重复序列及其相关蛋白9系统实现对HBV基因组高效靶向修饰,从而达到根治HBV感染的目的已经成为当前国内外学者关注的焦点。现结合国内外最新研究成果,重点总结成簇的规律间隔短回文重复序列及其相关蛋白9基因编辑技术在抗HBV感染治疗中应用的最新进展,阐述其作为彻底根治HBV感染方案的潜在可能和挑战。 A lack of effective drugs and technical means to eradicate hepatitis B virus (HBV) is a bottleneck that limits the ability to fully cure HBV infection. Recently, genome-editing technology based on clustered regularly interspaced short palindromic repeats -associated protein 9 is an emerging technique for editing specific gene loci, which can specifically target HBV covalently closed circular DNA, effectively inhibits HBV DNA replication and regulates HBV functional protein expression, and is expected to become a powerful gene therapy tool for the complete eradication of HBV. Considering this, it has become the focus of attention for scholars at home and abroad that how to use clustered regularly interspaced short palindromic repeats -associated protein 9 to accomplish modification of HBV genomes for complete eradication of HBV. This paper summarizes the latest progress based on the latest research results at home and abroad in the application of clustered regularly interspaced short palindromic repeats -associated protein 9 gene editing technology in anti-HBV infection treatment, and expounds its potential and challenges as a radical cure for HBV infection.
作者 王亚东 梁乾飞 李子月 赵彩彦 Wang Yadong;Liang Qianfei;Li Ziyue;Zhao Caiyan(Department of Infectious Diseases,the Third Affiliated Hospital of Hebei Medical University,Shijiazhuang 050035,China)
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2018年第11期860-864,共5页 Chinese Journal of Hepatology
关键词 肝炎病毒 乙型 基因编辑 共价闭合环状DNA 成簇的规律间隔短回文重 复序列及其相关蛋白9 Hepatitis B virus Gene editing Covalently closed circle DNA Clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9
  • 相关文献

参考文献3

二级参考文献20

  • 1Poordad F, McCone J, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP. Boceprevir for untreated chronic HCV genotype 1 infection. N Etzgl J Med ,2011, 364: 1195-1206 [PMID: 21449783 DOI: 10.1056/NEJ Moa1010494].
  • 2Sherman KE, Flamm SL, Afdhal NH, Nelson DR, Sulkowski MS, Everson GT, Fried MW, Adler M, Reesink HW, Martin M, Sankoh AJ, Adda N, Kauffman RS, George S, Wright CI, Poordad F. Response-guided telaprevir combination treatment for hepatitis C virus infection. N Eugl ] Med ,2011, 365:1014-1024 [PMID: 21916639 DOI: 10.1056/NEJMoa1014463].
  • 3Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122--a key factor and therapeutic target in liver disease. ] Hepatol ,2015, 62:448-457 [PMID: 25308172 DOI: 10.1016/j.jhep.,2014.10.004].
  • 4Henke JI, Goergen D, Zheng J, Song Y, Sch0ttler CG, Fehr C, JiJnemann C, Niepmann M. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO ] ,2008, 27:3300-3310 [PMID: 19020517 DOI: 10.1038/emboj.,2008.244].
  • 5Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science ,2005, 309:1577-1581 [PMID: 16141076].
  • 6Machlin ES, Sarnow P, Sagan SM. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target.RNA complex. Proc Natl Acad Sci U S A ,2011, 108:3193-3198 [PMID: 21220300 DOI: 10.1073/ pnas.1012464108].
  • 7Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA- guided DNA endonudease in adaptive bacterial immunity. Science ,2012, 337:816-821 [PMID: 22745249 DOI: 10.1126/science.1225829].
  • 8Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science ,2014, 346:1258096 [PMID: 25430774 DOI: 10.1126/science.1258096].
  • 9Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lira WA. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell ,2013, 152:1173-1183 [PMID: 23452860 DOI: 10.1016/j.cell.,2013.02.022].
  • 10Yin H, Xue W, Chen S, Bogorad RL, Benedetti E, Grompe M, Koteliansky V, Sharp PA, Jacks T, Anderson DG. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol ,2014, 32:551-553 [PMID: 24681508 DOI: 10.1038/nbt.2884].

共引文献18

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部